Efficacy and Safety Study of ZOMETA® in Treatment of High-level NTX Non Small Cell Lung Cancer With Bone Metastasis
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
A multicenter prospective study to assess the efficacy and safety of ZOMETA® in treatment of
high-level NTX non small cell lung cancer with bone metastasis.